<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04686240</url>
  </required_header>
  <id_info>
    <org_study_id>internalthoracicarterydoppler</org_study_id>
    <nct_id>NCT04686240</nct_id>
  </id_info>
  <brief_title>Doppler Ultrasonographic Assessment of Fetal Internal Thoracic Artery Indexes</brief_title>
  <official_title>Doppler Ultrasonographic Assessment of Fetal Internal Thoracic Artery Indexes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara City Hospital Bilkent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara City Hospital Bilkent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the feasibility of visualizing the internal thoracic&#xD;
      artery (ITA), establishing the normogram for ITA pulsatility index (PI), resistance index&#xD;
      (RI) and acceleration/ejection time (AT/ET) at 24-32 weeks.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: The internal thoracic artery arises from the subclavian artery as the first&#xD;
      branch. It travels downward on the inside of the rib cage and then gives off six main&#xD;
      branches; mediastinal, thymic, pericardiacophrenic, sternal, perforating and intercostal&#xD;
      branches.&#xD;
&#xD;
      In literature, there are so many articles that have been focused on thymus size in&#xD;
      pregnancies complicated with diabetes mellitus, fetal growth restriction, preterm rupture of&#xD;
      membranes and so on. To the best of our knowledge, there is no paper about fetal ITA whose&#xD;
      branch are feeding vessel of thymus and ITA Doppler velocity. The arteries supplying the&#xD;
      thymus are branches of the internal thoracic, and inferior thyroid arteries. As far as it has&#xD;
      been known, growing of a tissue depends on increased blood flow. Before detecting possible&#xD;
      blood-flow changes in fetuses complicated with great obstetrics patologies, the investigators&#xD;
      should obtain normal values of ITA Doppler velocity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2021</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Doppler indices for internal thoracic artery</measure>
    <time_frame>Between 24th and 32nd gestational weeks</time_frame>
    <description>Doppler indices (pulsatility index, resistance index, acceleration and ejection time)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>assessment of fetal thymus size</measure>
    <time_frame>Between 24th and 32nd gestational weeks</time_frame>
    <description>volume and perimeter and transvers diameter</description>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Pregnancy Related</condition>
  <condition>Fetal; Circulation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        healthy fetuses between 24th and 32nd gestational weeks&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  singleton pregnancy&#xD;
&#xD;
          -  having no fetal anomalies&#xD;
&#xD;
          -  healthy pregnant women age &gt;17 and &lt;45 years&#xD;
&#xD;
          -  between 24th-32nd gestational weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  fetuses with congenital aneuploidy or structural malformation&#xD;
&#xD;
          -  underlying chronic diseases&#xD;
&#xD;
          -  pregnant women complicated with gestational diabetes, Type 1-2 DM, hypertension&#xD;
             (pregnancy-induced; chronic; preeclampsia), malignancy&#xD;
&#xD;
          -  pregnancy complicated with preterm premature rupture of membranes, preterm labour,&#xD;
             fetal growth restriction and another obstetric complication&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant</gender_description>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>betül yakıştıran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ankara City Hospital Bilkent</affiliation>
  </overall_official>
  <overall_official>
    <last_name>aykan yücel, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ankara City Hospital Bilkent</affiliation>
  </overall_official>
  <overall_official>
    <last_name>mihriban alkan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ankara City Hospital Bilkent</affiliation>
  </overall_official>
  <overall_official>
    <last_name>seval erdinç, assoc prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>ankara city hospitalBilkent</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>betül yakıştıran, MD</last_name>
    <phone>+905464296321</phone>
    <email>btlengin@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>aykan yücel, professor</last_name>
    <phone>+905323851110</phone>
    <email>aykanyucel@gmail.com</email>
  </overall_contact_backup>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 22, 2020</study_first_submitted>
  <study_first_submitted_qc>December 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 28, 2020</study_first_posted>
  <last_update_submitted>December 24, 2020</last_update_submitted>
  <last_update_submitted_qc>December 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara City Hospital Bilkent</investigator_affiliation>
    <investigator_full_name>Betül Yakıştıran</investigator_full_name>
    <investigator_title>specialist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Persistent Fetal Circulation Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

